Japanese Trade Distributors Stock News

TSE:6752
TSE:6752Consumer Durables

Panasonic Holdings (TSE:6752) Could Be 20% Overvalued Following Lithium Ion Battery Growth Forecast

Custom Market Insights has released a new forecast for the global lithium ion battery market, highlighting Panasonic Holdings (TSE:6752) as a key participant in projected demand tied to energy storage and electric vehicles. See our latest analysis for Panasonic Holdings. At a share price of ¥4,480.0, Panasonic Holdings has seen a 19.28% 1 month share price return and a 56.59% 3 month share price return, contributing to a 1 year total shareholder return of 215.52%. This reflects strong recent...
TSE:8278
TSE:8278Consumer Retailing

Is Fuji (TSE:8278) Undervalued As It Keeps Guidance And Dividends Steady?

Fuji (TSE:8278) has come into focus after management reaffirmed full year guidance and dividend expectations, even as recent disclosures showed one quarter with stronger profitability and another with sharply weaker margins and earnings. See our latest analysis for Fuji. Fuji’s share price, at ¥1,971.0, has slipped over the year to date with a 7.25% decline in year to date share price return and a 12.09% decline over 90 days, while the 3 year total shareholder return of 14.56% suggests the...
TSE:7203
TSE:7203Auto

Canon Stock, Toyota And Daiichi Sankyo For Dividend Income In Japan

With inflation trends mixed across regions and central banks staying cautious, many investors are looking for steadier sources of cash return rather than trying to guess the next growth story. The Dividend Powerhouses screener focuses on companies paying more than a 5% dividend yield, with those payouts covered, growing and relatively stable, which can be appealing when bond yields and policy expectations keep shifting. This article walks through three of the best stocks from that screener,...
TSE:5711
TSE:5711Metals and Mining

Is Mitsubishi Materials (TSE:5711) Undervalued On Convertible Bond Plans?

Board meeting puts Mitsubishi Materials’ financing plans in focus Mitsubishi Materials (TSE:5711) has called a board meeting for 8 July 2026 to review issuing zero coupon convertible bonds maturing in 2030 and 2032, a financing step that could matter for shareholders. See our latest analysis for Mitsubishi Materials. The board meeting takes place at a time when Mitsubishi Materials’ share price has been under pressure in recent months, with a 7 day share price return of down 10.27% and a 90...
TSE:3769
TSE:3769Diversified Financial

How Investors May Respond To GMO Payment Gateway (TSE:3769) ¥10 Billion A-Rated Bond Issuance

GMO Payment Gateway, Inc. has issued its 3rd unsecured straight bond in Japan, raising ¥10 billion via three-year notes paying a 2.286% annual coupon, with proceeds earmarked for investment, lending, and working capital. An A- rating from Rating and Investment Information, Inc. underpins this financing move, signaling lender confidence in the company’s credit profile and its capacity to support ongoing digital payments expansion. We will now examine how this ¥10 billion bond issuance, and...
TSE:6963
TSE:6963Semiconductor

ROHM (TSE:6963) Launches New MOSFET Series, Is The Upside Already Priced In?

ROHM (TSE:6963) has drawn fresh attention after ROHM Semiconductor introduced its new 600V Super Junction MOSFET series, R60xxXNx and R60xxWNx, designed to support higher efficiency and more compact power supplies for data centers and industrial equipment. See our latest analysis for ROHM. The product launch comes as ROHM’s share price has climbed strongly this year, with a 90 day share price return of 53.38% and a year to date share price return of 145.88%. The 1 year total shareholder...
TSE:4503
TSE:4503Pharmaceuticals

FDA’s PADCEV Keytruda Approval for All MIBC Patients Might Change The Case For Investing In Astellas Pharma (TSE:4503)

Pfizer and Astellas Pharma recently announced that the U.S. FDA approved PADCEV (enfortumab vedotin-ejfv) plus Keytruda as both neoadjuvant and adjuvant treatment for adult patients with muscle-invasive bladder cancer, regardless of cisplatin eligibility, based on positive Phase 3 EV-304 trial data versus standard gemcitabine-cisplatin chemotherapy. This marks the first platinum-free regimen approved for all muscle-invasive bladder cancer patients, materially expanding the clinical and...
TSE:6501
TSE:6501Industrials

3 Japanese Nuclear Energy Stocks Tied To Power Grids And AI Demand

With inflation, interest rates and energy prices all under scrutiny, many investors are looking for exposure to power sources that aim to be both reliable and relatively low carbon. Nuclear energy stocks sit at the crossroads of these themes, tied to both commodity markets and long term electricity demand. The Nuclear Energy Stocks screener focuses on companies involved in uranium production, fuel enrichment and reactor projects, offering a focused way to research this corner of the market...
TSE:9697
TSE:9697Entertainment

Japanese Growth Stocks With High Insider Ownership That Deserve A Closer Look

With inflation, interest rate decisions and energy costs all pulling markets in different directions, many investors are looking for companies where growth expectations are backed by the people who know the business best: management and insiders. The Fast Growing Stocks With High Insider Ownership screener focuses on exactly that, highlighting companies where analysts see strong potential and insiders hold meaningful stakes. That combination can help align management decisions with...
TSE:6902
TSE:6902Auto Components

DENSO (TSE:6902) Could Be 46% Below Fair Value Following Battery Passport Trial

DENSO stock: why a battery passport trial matters for investors DENSO (TSE:6902) is in focus after working with TÜV Rheinland Japan and AESC Group on a battery passport validation that aligns with EU Battery Regulation requirements for energy storage systems. The project used real data from AESC's energy storage business and confirmed that DENSO's battery passport service can support traceability, data security and regulatory compliance for products headed to Europe. See our latest analysis...
TSE:4443
TSE:4443Software

Rorze Stock And 2 Japanese Founder Led Picks For AI Infrastructure

Global inflation, interest rate signals and energy costs are keeping markets on edge, which makes it harder for you to judge which executives truly have skin in the game. The Founder-Led Companies screener focuses on leaders who built their businesses and remain personally committed to long term performance so their incentives stay closely aligned with shareholders. Instead of trying to predict every central bank move, you can focus on these founder backed stocks, where leadership continuity...
TSE:2670
TSE:2670Specialty Retail

ABC-MartInc (TSE:2670) Reports Weaker June Sales, Is The Discount Too Pessimistic?

ABC-MartInc (TSE:2670) drew investor attention after reporting June 2026 sales, with all stores and existing stores both showing a 6.6% decline compared with growth just over 6% a year earlier. See our latest analysis for ABC-MartInc. At a share price of ¥2,620.5, ABC-MartInc has seen its short term momentum soften, with the 7 day share price return down 6.41% and the 30 day share price return down 4.81%, while the 5 year total shareholder return of 46.43% points to a stronger longer term...
TSE:6723
TSE:6723Semiconductor

SK Hynix Listing Puts These AI Semiconductor Stocks On Retail Investors’ Radar

The record US$26.5b Nasdaq listing of SK Hynix has put AI semiconductor stocks firmly back in the spotlight, with investors watching how fresh capital for high bandwidth memory and AI chip production might ripple through the sector. With bookbuilding reportedly 7x oversubscribed and expectations that the new ADR could influence how similar businesses are valued, this news is hard to ignore if you follow AI hardware. Below, you will see 3 stocks from our AI Semiconductor Stocks screener that...
TSE:6407
TSE:6407Machinery

CKD (TSE:6407) Following Embezzlement Arrest, Does Its Valuation Still Hold Up?

CKD (TSE:6407) is in focus after disclosing that a former accounting staff member at subsidiary CKD GLOBAL SERVICE CORP. was arrested for embezzling ¥178 million, which was fully booked in the latest fiscal year. See our latest analysis for CKD. Despite the embezzlement headline, CKD’s recent 30 day share price return of 16.8% and year to date share price return of 127.72% indicate strong momentum. The 1 year total shareholder return of 184.55% highlights how reinvested dividends have added...
TSE:8035
TSE:8035Semiconductor

3 Japanese AI Chip Stocks With Strong Balance Sheets

Cooling inflation in several major economies, mixed but resilient growth signals, and central banks stressing data dependence have pushed many investors toward companies with solid balance sheets and disciplined use of capital. In this setting, stocks that combine high return on equity, a history of sound execution, and robust financial foundations can offer a cleaner way to gain exposure without relying heavily on momentum or aggressive forecasts. This article focuses on our Solid Balance...
TSE:9956
TSE:9956Consumer Retailing

Is Valor Holdings (TSE:9956) Fairly Valued After Its Alliance Stock Split And Equity Raise?

Valor Holdings (TSE:9956) has set out a multi pronged plan that includes a capital and business alliance with KOHNAN SHOJI, a stock split, amended articles of incorporation, and a follow on equity offering. See our latest analysis for Valor Holdings. Valor Holdings' share price has eased in recent months, with a 30 day share price return of 9.42% and a 90 day return of 16.15% in decline. However, the 1 year total shareholder return of 28% and 3 year total shareholder return of 76.49% point to...
TSE:7921
TSE:7921Commercial Services

Takara (TSE:7921) Stock Faces Margin Compression As Net Profitability Undercuts Bullish Narratives

Takara (TSE:7921) has wrapped up FY 2026 with fourth quarter revenue of ¥8.8 billion and basic EPS of ¥131.69, capping a year in which trailing twelve month revenue was ¥31.2 billion and EPS reached ¥261.92. Over recent quarters, revenue has ranged from ¥6.3 billion to ¥9.1 billion, while quarterly EPS has moved between ¥11.48 and ¥182.98, giving investors a clear view of how earnings power has shifted across the year. With a current net margin of 10.9% versus 13.7% a year earlier, the focus...
TSE:4704
TSE:4704Software

AI Stocks To Watch In Japan As Enterprise Software Growth Picks Up

The AI boom is no longer just a tech story. It now touches chips, cloud, software and every corner of the market where companies are looking to automate, cut costs and process data more efficiently. With central banks watching inflation, energy prices moving and growth signals mixed across regions, many investors are using focused tools to sort signal from noise. This AI Stocks screener zeroes in on businesses directly tied to semiconductors, large language models and ChatGPT related...
TSE:6366
TSE:6366Construction

Chiyoda (TSE:6366) Stock Looks Cheap On Cash Flow Despite A 109% Run

Chiyoda stock has returned 109.5% over the past year, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiple checks still point to the shares trading below what the fundamentals imply. Over the last 12 months, Chiyoda has delivered a 109.5% share price return, which puts more focus on whether there is still valuation headroom after such a strong run. Expectations for future cash flows can support the current pricing, while any setback in converting projects...
TSE:268A
TSE:268AElectronic

Does Rigaku Holdings' New Osaka Training Center Reveal a Deeper Services Strategy for (TSE:268A)?

Rigaku Corporation recently opened the Rigaku Solutions Center Osaka at its Osaka Plant, creating a centralized hub with a new cleanroom to deliver hands-on training for field service engineers who support semiconductor metrology systems. By standardizing service practices and expanding advanced, practical training for engineers and distribution partners worldwide, the facility meaningfully deepens Rigaku’s support infrastructure for semiconductor industry customers. We’ll now examine how...
TSE:3498
TSE:3498Real Estate

How Investors May Respond To Kasumigaseki Capital (TSE:3498) FY26 Guidance and Shareholder Benefit Review

In early July 2026, Kasumigaseki Capital Co., Ltd. issued consolidated earnings guidance for the fiscal year ending August 31, 2026, forecasting net sales of ¥150,000 million, operating profit of ¥26,500 million, profit attributable to owners of parent of ¥16,500 million, and basic earnings per share of ¥672.42. At the same July 3, 2026 board meeting, the company also considered changes to its shareholder benefit program, signaling potential adjustments to how returns are structured for...
TSE:4502
TSE:4502Pharmaceuticals

Takeda Pharmaceutical (TSE:4502) Taps Pharma.AI For Drug Discovery, Is The Stock Still Cheap?

Takeda Pharmaceutical (TSE:4502) has drawn fresh investor attention after agreeing to work with Insilico Medicine’s Pharma.AI platform, which ties its drug discovery pipeline more closely to artificial intelligence based molecule design. See our latest analysis for Takeda Pharmaceutical. The Pharma.AI collaboration lands at a time when Takeda Pharmaceutical’s share price has risen 8.5% year to date, while its 1-year total shareholder return of 26.82% points to solid long-term momentum,...